FICORELLA, CORRADO
 Distribuzione geografica
Continente #
EU - Europa 280
AS - Asia 47
NA - Nord America 43
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 7
AF - Africa 1
Totale 392
Nazione #
IT - Italia 272
US - Stati Uniti d'America 39
SG - Singapore 16
CN - Cina 14
VN - Vietnam 8
BR - Brasile 4
HK - Hong Kong 3
CA - Canada 2
DE - Germania 2
EC - Ecuador 2
FR - Francia 2
AR - Argentina 1
BD - Bangladesh 1
CR - Costa Rica 1
DK - Danimarca 1
FI - Finlandia 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
MX - Messico 1
OM - Oman 1
PH - Filippine 1
RU - Federazione Russa 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 378
Città #
Genoa 118
Genova 87
Rapallo 35
Vado Ligure 31
San Jose 12
Singapore 8
Ashburn 4
Beijing 3
Hanoi 3
Ho Chi Minh City 3
Hong Kong 3
Cleveland 2
Columbus 2
Frankfurt am Main 2
Lauterbourg 2
Budapest 1
Cadoneghe 1
Cartago 1
Cherry Hill 1
Chester 1
Copenhagen 1
Council Bluffs 1
Fort Myers 1
García 1
Gloversville 1
Haiphong 1
Hamilton 1
Helsinki 1
Kuwait City 1
Lambari 1
Los Baños 1
Mauá 1
Mentor 1
Miami 1
Milagro 1
Montreal 1
Newark 1
Pasadena 1
Quito 1
Salvador 1
San Juan Bautista 1
Seeb 1
St Louis 1
Tashkent 1
Teresina 1
Tomsk 1
Washington 1
Totale 347
Nome #
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence 189
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy 108
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 95
Totale 392
Categoria #
all - tutte 1.588
article - articoli 1.588
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 1 0 1 1 2 2 2 12 2 2 5
2022/202345 6 2 0 5 9 4 0 6 6 4 3 0
2023/202427 1 5 1 4 3 2 0 0 1 3 2 5
2024/202578 5 4 3 6 9 10 3 15 6 6 3 8
2025/2026129 20 3 7 13 21 8 22 7 6 7 2 13
2026/202715 15 0 0 0 0 0 0 0 0 0 0 0
Totale 392